MELODY DEANGELIS: Open Payments
NPI 1205387883 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 16 payments from 7 companies in 2025. Trend: 2023 $328 · 2024 $344 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $354 |
| Globus Medical, Inc. | 1 | $33 |
| Averitas Pharma Inc. | 1 | $30 |
| Atland Pharmaceuticals, LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Forte Bio-Pharma LLC | 1 | $19 |
Products named: BOTOX, Senza, QUTENZA, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, Belbuca, RELISTOR, PROLATE.
Industry payments across SC — which companies pay providers there.
